SRNE

Sorrento Therape (SRNE)

US
$ 00%

Price Chart

Key Statistics

Market Cap
$ 716.67K
P/E Ratio
0.00
Revenue (TTM)
$ 64.27M
Volume
0
52W High
$ 0.02
52W Low
$ 0.00
Dividend Yield
0.00%
Beta
1.13

Technicals

50-Day MA
0.0014
200-Day MA
0.0021
52 Week High
0.021
52 Week Low
0.0001

About SRNE

Sorrento Therapeutics, Inc., a clinical and commercial stage biopharmaceutical company, develops a portfolio of next-generation treatments for three therapeutic areas: cancer, infectious disease,and p.

Employees
949
Headquarters
San Diego, CA
CEO
Dr. Henry H. Ji Ph.D.

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg